ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1170

Expression and Function Of Human Mfg-E8 In The Clearance Of Apoptotic Cells and Suppression Of Inflammation

Lucrezia Colonna1, Jie An2, Xizhang Sun3, Nalini Agrawal4, Alice Wiedeman5 and Keith B. Elkon3, 1Department of Medicine, Division of Rheumatology, University of Washington, Seattle, WA, 2Division of Rheumatology, Department of Medicine & Immunology, University of Washington, Seattle, WA, 3Division of Rheumatology, University of Washington, Seattle, WA, 4Rheumatology, University of Washington, Seattle, WA, 5Immunology, University of Washington, Seattle, WA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: apoptotic clearance, Dendritic cells, inflammatory cytokines, macrophages and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Innate Immunity and Rheumatic Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Effective clearance of apoptotic cells (AC) is necessary for the maintenance of tolerance to self. MFG-E8 is one of ~20 different opsonins reported to promote AC clearance in mice. Deficiency of MFG-E8 on certain strain backgrounds promotes a lupus-like disease in mice. However, very little is known about the expression and function of MFG-E8 in humans, and its potential role in systemic lupus erythematosus (SLE). The goals of this study were to examine the expression and function of MFG-E8 in human phagocytes and its potential role in SLE.  

Methods: Macrophages and dendritic cells (DC) were derived from monocytes by culture with M-CSF or GM-CSF and IL-4 respectively. MFG-E8 expression and secretion were quantified by flow cytometry (FACS) and ELISA respectively. Phagocytosis of AC was quantified by microscopy (phagocytic index) and by FACS using CFSE-labeled AC. Phagocytes were stimulated by LPS (1 ng/ml) or zymosan (50ug/ml) and cytokines quantified by ELISA.

Results: MFG-E8 expression and function was very different in human macrophages and DCs. Unlike murine thioglycollate-elicited macrophages, human macrophages did not express or secrete MFG-E8. However, when MFG-E8 was added to AC, increased cell clearance was observed in a dose responsive manner. Furthermore, specific addition of MFG-E8 to AC resulted in suppression of TNF and IL-1b in response to LPS and zymosan. In striking contrast, human DCs expressed high levels of intracellular and cell surface MFG-E8 but exogenous MFG-E8 addition to AC did not enhance DC-mediated AC uptake. Remarkably, at higher doses MFG-E8 actually exerted an inhibitory effect on AC clearance by DC.  

Conclusion: These results suggest that MFG-E8 plays an important role in clearance of AC by macrophages in humans. In addition, coating of AC by MFG-E8 alone enhances the known anti-inflammatory effects of AC by further dampening the production of pro-inflammatory cytokines such as TNF and IL-1b. Surprisingly, human DC did not seem to be functionally impacted by MFG-E8 coated AC despite or, perhaps, because MFG-E8 was expressed at high concentrations on the surface of these cells. We propose that MFG-E8 plays a central role in AC clearance and dampening inflammatory responses in human macrophages. It should therefore be considered as a therapeutic to enhance AC clearance and suppress inflammation in lupus and, possibly, other autoimmune disorders.


Disclosure:

L. Colonna,
None;

J. An,
None;

X. Sun,
None;

N. Agrawal,
None;

A. Wiedeman,
None;

K. B. Elkon,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/expression-and-function-of-human-mfg-e8-in-the-clearance-of-apoptotic-cells-and-suppression-of-inflammation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology